Kataoka, T <br/><br/>
The caspase-8 inhibitor FLIP promotes activation of NF-kappaB and Erk signaling pathways.  [electronic resource] 

 -  Current biology : CB  Jun 2000 
 - 640-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0960-9822 
<br/><br/><label>Standard No.: </label>10.1016/s0960-9822(00)00512-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Apoptosis<br/>CASP8 and FADD-Like Apoptosis Regulating Protein<br/>CD3 Complex--physiology<br/>Carrier Proteins--metabolism<br/>Caspase 8<br/>Caspase 9<br/>Caspase Inhibitors<br/>Cells, Cultured<br/>Fas Ligand Protein<br/>Humans<br/>Interleukin-2--biosynthesis<br/>Intracellular Signaling Peptides and Proteins<br/>Membrane Glycoproteins--pharmacology<br/>Mitogen-Activated Protein Kinases--metabolism<br/>NF-kappa B--metabolism<br/>Proteins--metabolism<br/>Proto-Oncogene Proteins c-raf<br/>Receptor-Interacting Protein Serine-Threonine Kinases<br/>Receptors, Tumor Necrosis Factor--physiology<br/>Signal Transduction--drug effects<br/>T-Lymphocytes--drug effects<br/>TNF Receptor-Associated Factor 1<br/>TNF Receptor-Associated Factor 2<br/>Transcription Factor AP-1--metabolism<br/>fas Receptor--physiology